share_log

Guggenheim Downgrades Deciphera Pharmaceuticals to Neutral

Guggenheim Downgrades Deciphera Pharmaceuticals to Neutral

古根海姆下調Deciphera Pharmicals的評級至中性
Benzinga ·  04/30 13:03

Guggenheim analyst Michael Schmidt downgrades Deciphera Pharmaceuticals (NASDAQ:DCPH) from Buy to Neutral.

古根海姆分析師邁克爾·施密特將Deciphera Pharmicals(納斯達克股票代碼:DCPH)的評級從買入下調至中性。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論